Physician profile
Agnes E Glover
NPI 1568575470
$4,530.41
in general payments reported to CMS, 2019-2025
15 companies · $1,634 in 2025
The $1,634 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $75.84 · 2021: $322 · 2022: $128 · 2023: $34.64 · 2024: $2,136 · 2025: $1,634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,000 · Travel and Lodging: $1,523 · Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,000.00 |
| Travel and Lodging | $1,523.03 |
| Food and Beverage | $281.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,572.19 | 2024-2025 | |
| Hologic Sales and Service, LLC | $316.75 | 2019-2025 | Acessa Provu System, Coolseal Generator |
| Abbvie INC. | $284.23 | 2019-2022 | |
| Coopersurgical, INC. | $98.51 | 2021-2025 | Endosee, Paragard T 380a |
| Minerva Surgical, INC | $42.78 | 2020-2021 | |
| Allergan, INC. | $32.86 | 2019-2021 | |
| Aspira Women'S Health INC | $28.38 | 2022 | |
| Ethicon US, LLC | $26.87 | 2021 | |
| Lupin INC. | $24.46 | 2019 | |
| Daiichi Sankyo INC. | $21.08 | 2019 | |
| Covidien Lp | $19.93 | 2019 | |
| Merck Sharp & Dohme LLC | $19.82 | 2019 | |
| Organon LLC | $16.40 | 2022 | |
| Heron Therapeutics, INC. | $15.36 | 2025 | Aponvie |
| Amag Pharmaceuticals, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agnes Glover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.